SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10

BACKGROUND: SLC/CCL21, normally expressed in high endothelial venules and in T cell zones of spleen and lymph nodes, strongly attracts T cells and dendritic cells (DC). We have previously shown that SLC/CCL21-mediated anti-tumor responses are accompanied by significant induction of IFNγ and the CXC...

詳細記述

書誌詳細

出版年:	Mol Cancer
主要な著者:	Sharma, Sherven, Yang, Seok-Chul, Hillinger, Sven, Zhu, Li X, Huang, Min, Batra, Raj K, Lin, Jeff F, Burdick, Marie D, Strieter, Robert M, Dubinett, Steven M
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2003
主題:	Research
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC155639/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12740040/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1476-4598-2-22
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!